newsfilter
← Latest News
GlobeNewswire·

Alimera Sciences Reports Second Quarter 2024 Results

Net Revenue up 54% to $27 Million vs. Q2 2023Global End User Demand up 6% vs. Q2 2023Company Recently Announced Definitive Merger Agreement with ANI Pharmaceuticals, Inc. ATLANTA, Aug. 06, 2024